CORT EBITDA | CORCEPT THERAPEUTICS INC

CORCEPT THERAPEUTICS INC (CORT) EBITDA

2026-06-30: Basis Reported; EBITDA $42.16M*; Operating income $41.30M; Depreciation and amortization $863.00K*.
2026-03-31: Basis Reported; EBITDA -$49M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $4.78M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $10.15M*; Operating income $10.22M; Depreciation and amortization -$71.00K*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$42.16M*	$41.30M	$863.00K*	$256.15M	16.46%*	$2.53M*	$33.54M*	$4.06M	$53.89M	$156.90M	$2.94M
2026-03-31	Reported	-$49M	(m)	(m)	(m)	-29.72%	$201.00K	-$16.77M	$2.88M	$66.27M	$145.36M	-$12.95M
2025-12-31	Reported	$4.78M	(m)	(m)	(m)	2.36%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$10.15M*	$10.22M	-$71.00K*	$207.64M	4.89%*	$0.00*	$54.48M*	$4.60M	$68.85M	$123.98M	-$4.42M
2025-06-30	Reported	$27.14M*	$26.68M	$469.00K*	$194.43M	13.96%*	$57.00K*	$44.30M*	$3.43M	$60.47M	$103.85M	-$3.46M
2025-03-31	Reported	$3.88M	(m)	(m)	(m)	2.47%	$104.00K	$4.77M	$2.40M	$60.73M	$90.66M	-$10.93M
2024-12-31	Reported	$25.54M	(m)	(m)	(m)	14.04%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$46.92M*	$46.60M	$318.00K*	$182.55M	25.70%*	$1.64M*	$73.29M*	$2.87M	$59.34M	$73.75M	$5.73M
2024-06-30	Reported	$35.67M*	$35.59M	$76.00K*	$163.80M	21.78%*	$416.00K*	$41.19M*	$2.52M	$58.74M	$66.94M	$6.11M
2024-03-31	Reported	$29.62M	(m)	(m)	(m)	20.18%	$0.00	$23.76M	$2.54M	$58.51M	$56.27M	$7.23M
2023-12-31	Reported	$31.88M	(m)	(m)	(m)	23.55%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$31.41M*	$31.18M	$232.00K*	$123.60M	25.41%*	$37.00K*	$52.91M*	$1.65M	$45.52M	$45.26M	$5.01M
2023-06-30	Reported	$30.01M*	$29.58M	$424.00K*	$117.72M	25.49%*	$102.00K*	$42.29M*	$1.57M	$43.28M	$43.28M	$5.40M
2023-03-31	Reported	$15.03M	(m)	(m)	(m)	14.22%	$0.00	$25.96M	$1.39M	$40.85M	$48.56M	$2.56M
2022-12-31	Reported	$23.16M	(m)	(m)	(m)	22.47%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$32.13M*	$31.93M	$195.00K*	$101.73M	31.58%*	$351.00K*	$33.65M*	$1.34M	$33.29M	$35.16M	-$1.60M
2022-06-30	Reported	$31.55M*	$31.43M	$116.00K*	$103.39M	30.51%*	$19.00K*	$18.04M*	$1.32M	$32.83M	$37.81M	$4.65M
2022-03-31	Reported	$27.06M	(m)	(m)	(m)	28.88%	$12.00K	$35.25M	$1.25M	$28.12M	$37.55M	$4.05M
2021-12-31	Reported	$36.95M	(m)	(m)	(m)	37.39%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$34.54M*	$36.23M	-$1.69M*	$96.13M	35.93%*	$159.00K*	$48.70M*	$1.27M	$28.09M	$30.53M	$5.83M
2021-06-30	Reported	$34.16M*	$31.94M	$2.22M*	$91.59M	37.30%*	$119.00K*	$44.34M*	$1.38M	$28.23M	$30.03M	$5.53M
2021-03-31	Reported	$19.89M	(m)	(m)	(m)	25.04%	$126.00K	$25.42M	$1.27M	$29.02M	$29.51M	-$3.55M
2020-12-31	Reported	$30.59M	(m)	(m)	(m)	35.68%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$24.80M*	$24.72M	$85.00K*	$86.33M	28.73%*	$718.00K*	$30.44M*	$1.22M	$33.87M	$26.52M	$3.72M
2020-06-30	Reported	$35.39M*	$35.26M	$124.00K*	$88.56M	39.95%*	$47.00K*	$53.19M*	$1.23M	$26.50M	$25.57M	$7.95M
2020-03-31	Reported	$37.95M	(m)	(m)	(m)	40.70%	$42.00K	$33.27M	$1.88M	$26.12M	$27.54M	$9.12M
2019-12-31	Reported	$35.25M	(m)	(m)	(m)	40.10%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$33.22M*	$33.00M	$211.00K*	$81.50M	40.75%*	$286.00K*	$38.43M*	$1.45M	$22.80M	$24.25M	$8.01M
2019-06-30	Reported	$24.80M*	$24.63M	$167.00K*	$72.26M	34.32%*	$410.00K*	$25.55M*	$1.38M	$21.66M	$24.59M	$5.63M
2019-03-31	Reported	$19.05M	(m)	(m)	(m)	29.39%	$257.00K	$23.68M	$1.24M	$20.24M	$24.39M	$1.78M
2018-12-31	Reported	$24.97M	(m)	(m)	(m)	37.36%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	$23.03M*	$22.97M	$58.00K*	$64.44M	35.73%*	$45.00K*	$44.51M*	$1.31M	$18.86M	$21.31M	$5.98M
2018-06-30	Reported	$20.69M*	$20.63M	$57.00K*	$62.31M	33.21%*	$63.00K*	$15.21M*	$1.15M	$20.54M	$19.98M	$3.00M
2018-03-31	Reported	$21.04M	(m)	(m)	(m)	36.50%	$77.00K	$34.43M	$1.17M	$17.05M	$18.44M	$3.83M
2017-12-31	Reported	$21.75M	(m)	(m)	(m)	40.81%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$13.66M*	$13.62M	$36.00K*	$42.76M	31.94%*	$82.00K*	$10.93M*	$976.00K	$11.69M	$16.47M	-$48.00K
2017-06-30	Reported	$12.80M*	$12.79M	$9.00K*	$35.56M	36.01%*	$198.00K*	(m)	$775.00K	$7.88M	$14.11M	$50.00K
2017-03-31	Reported	$4.75M	(m)	(m)	(m)	(m)	$110.00K	(m)	(m)	$7.18M	$15.04M	$127.00K
2016-12-31	Reported	$5.02M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$3.09M*	$3.07M	$21.00K*	(m)	(m)	$90.00K*	(m)	(m)	$7.05M	$10.93M	$0.00
2016-06-30	Reported	$1.53M*	$1.51M	$24.00K*	(m)	(m)	$7.00K*	(m)	(m)	$5.67M	$12.12M	$0.00
2016-03-31	Reported	$619,000.00	(m)	(m)	(m)	(m)	$22.00K	(m)	(m)	$4.63M	$10.43M	$0.00
2015-12-31	Reported	$1.68M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	$132.00K*	$102.00K	$30.00K*	(m)	(m)	$0.00*	(m)	(m)	$3.61M	$9.29M	(m)
2015-06-30	Reported	-$1.11M*	-$1.17M	$57.00K*	(m)	(m)	$0.00*	(m)	(m)	$3.34M	$9.34M	(m)
2015-03-31	Reported	-$3.99M	(m)	(m)	(m)	(m)	$34.00K	(m)	(m)	$4.38M	$9.45M	(m)
2014-12-31	Reported	-$3.04M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$5.06M*	-$5.10M	$39.00K*	(m)	(m)	$16.00K*	(m)	(m)	$3.05M	$9.10M	(m)
2014-06-30	Reported	-$6.54M*	-$6.58M	$37.00K*	(m)	(m)	$48.00K*	(m)	(m)	$4.25M	$7.96M	(m)
2014-03-31	Reported	-$12.83M	(m)	(m)	(m)	(m)	$110.00K	(m)	(m)	$7.29M	$9.80M	(m)
2013-12-31	Reported	-$10.01M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$9.72M*	-$9.74M	$20.00K*	(m)	(m)	$65.00K*	-$8.60M*	(m)	$5.16M	$7.18M	(m)
2013-06-30	Reported	-$10.76M*	-$10.78M	$19.00K*	(m)	(m)	$4.00K*	-$9.24M*	(m)	$4.49M	$8.16M	(m)
2013-03-31	Reported	-$10.93M	(m)	(m)	(m)	(m)	$18.00K	-$11.55M	(m)	$4.26M	$8.38M	(m)
2012-12-31	Reported	-$9.97M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$7.67M*	-$7.67M	$6.00K*	(m)	(m)	$52.00K*	-$9.23M*	(m)	$3.01M	$5.69M	(m)
2012-06-30	Reported	(m)	-$7.59M	(m)	(m)	(m)	(m)	(m)	(m)	$2.67M	$5.75M	(m)
2012-06-30	Reported	-$7.59M*	-$7.59M	$5.00K*	(m)	(m)	$34.00K*	-$7.89M*	(m)	$2.67M	$5.75M	(m)
2012-03-31	Reported	-$11.03M	(m)	(m)	(m)	(m)	$7.00K	-$10.16M	(m)	$3.54M	$7.49M	(m)
2011-12-31	Reported	-$9.93M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$6.44M*	-$6.44M	$0.00*	(m)	(m)	(m)	-$6.60M*	(m)	$3.23M	$3.21M	(m)
2011-06-30	Reported	(m)	-$8.87M	(m)	(m)	(m)	(m)	-$7.21M*	(m)	$6.20M	$2.67M	(m)
2011-03-31	Reported	(m)	-$7.10M	(m)	(m)	(m)	(m)	-$7.29M	(m)	$4.92M	$2.17M	(m)
2010-12-31	Reported	-$7.82M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$7.10M*	-$7.11M	$1.00K*	(m)	(m)	(m)	-$6.43M*	(m)	$5.22M	(m)	(m)
2010-06-30	Reported	(m)	-$6.45M	(m)	(m)	(m)	(m)	(m)	(m)	$4.57M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$45.95M	(m)	(m)	(m)	6.03%	$211.00K	$142.00M	$12.98M	$254.91M	$448.73M	-$33.19M
2024-12-31	Reported	$137.75M	(m)	(m)	(m)	20.41%	$2.17M	$198.29M	$10.88M	$246.89M	$280.32M	$20.28M
2023-12-31	Reported	$108.32M	(m)	(m)	(m)	22.46%	$139.00K	$126.68M	$6.48M	$184.35M	$184.26M	$18.42M
2022-12-31	Reported	$113.89M	(m)	(m)	(m)	28.34%	$413.00K	$120.32M	$5.38M	$130.99M	$152.85M	$14.77M
2021-12-31	Reported	$125.55M	(m)	(m)	(m)	34.31%	$469.00K	$167.89M	$5.28M	$113.86M	$122.36M	$12.49M
2020-12-31	Reported	$128.73M	(m)	(m)	(m)	36.38%	$1.24M	$151.97M	$5.58M	$114.76M	$105.33M	$25.59M
2019-12-31	Reported	$112.31M	(m)	(m)	(m)	36.64%	$1.09M	$136.12M	$5.50M	$89.02M	$100.36M	$22.50M
2018-12-31	Reported	$89.73M	(m)	(m)	(m)	35.71%	$298.00K	$115.67M	$5.21M	$75.25M	$81.29M	$16.74M
2017-12-31	Reported	$52.96M	(m)	(m)	(m)	33.27%	$419.00K	$60.94M	$3.55M	$40.38M	$62.42M	-$76.32M
2016-12-31	Reported	$10.27M	(m)	(m)	(m)	12.62%	$194.00K	$18.39M	$2.06M	$23.84M	$45.24M	$0.00
2015-12-31	Reported	-$3.29M	(m)	(m)	(m)	(m)	$17.00K	(m)	(m)	$15.42M	$36.95M	$0.00
2014-12-31	Reported	-$27.48M	(m)	(m)	(m)	(m)	$174.00K	(m)	(m)	$18.37M	$34.92M	$0.00
2013-12-31	Reported	-$41.42M	(m)	(m)	(m)	(m)	$127.00K	-$37.06M	(m)	$20.47M	$31.24M	(m)
2012-12-31	Reported	-$36.25M	(m)	(m)	(m)	(m)	$151.00K	-$36.02M	(m)	$14.07M	$25.41M	(m)
2011-12-31	Reported	-$32.33M	(m)	(m)	(m)	(m)	$25.00K	-$27.40M	(m)	$21.00M	$11.33M	(m)
2010-12-31	Reported	-$27.43M	(m)	(m)	(m)	(m)	(m)	-$22.29M	(m)	$18.95M	$8.49M	(m)
2009-12-31	Reported	-$20.24M	(m)	(m)	(m)	-69793.10%	(m)	-$17.97M	(m)	$14.40M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
BIOMARIN PHARMACEUTICAL INC (BMRN)	United States	$11.879B	151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
Jazz Pharmaceuticals plc (JAZZ)		$15.333B	16.07
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52